LMAT

Dopo l'orario di chiusura: 98.63

Lemaitre Vascular Inc (LMAT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Lemaitre Vascular Inc

Healthcare (1182)

781-221-2266

63 SECOND AVENUE, BURLINGTON, MA

@LMAT_Vascular

Prossima data di guadagno

Ultimi documenti SEC

LMAT's Discussions on Twitter

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-06	Ripresa	KeyBanc Capital Markets	Sector Weight
2023-10-23	Iniziato	JMP Securities	Mkt Outperform
2023-09-06	Iniziato	Oppenheimer	Outperform
2023-08-03	Downgrade	Jefferies	Buy → Hold
2023-05-03	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2022-10-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2021-09-16	Iniziato	Jefferies	Buy
2021-02-12	Iniziato	KeyBanc Capital Markets	Sector Weight
2020-03-16	Aggiornamento	Sidoti	Neutral → Buy
2019-10-24	Downgrade	First Analysis Sec	Strong Buy → Outperform
2019-10-24	Aggiornamento	Lake Street	Hold → Buy
2019-10-14	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2019-07-25	Reiterato	Barrington Research	Outperform
2019-07-25	Aggiornamento	First Analysis Sec	Neutral → Outperform
2018-10-08	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2018-10-08	Aggiornamento	ROTH Capital	Neutral → Buy
2018-06-08	Ripresa	ROTH Capital	Buy
2018-04-26	Downgrade	Stifel	Buy → Hold
2018-04-26	Aggiornamento	The Benchmark Company	Hold → Buy
2017-10-27	Downgrade	First Analysis Sec	Overweight → Equal-Weight
2017-10-27	Downgrade	The Benchmark Company	Buy → Hold
2017-07-10	Downgrade	Canaccord Genuity	Buy → Hold
2017-07-10	Downgrade	The Benchmark Company	Buy → Hold
2017-03-21	Iniziato	First Analysis Sec	Overweight
2017-02-22	Downgrade	Barrington Research	Outperform → Mkt Perform
2016-09-22	Downgrade	Sidoti	Buy → Neutral
2016-07-28	Reiterato	Barrington Research	Outperform
2016-02-25	Reiterato	Barrington Research	Outperform

Mostra tutto

Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie

Lemaitre Vascular Inc Azioni (LMAT) Dati Finanziari

Lemaitre Vascular Inc (LMAT)

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie

LeMaitre Vascular's SWOT analysis: niche market leader's stock faces valuation scrutiny - Investing.com

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Harbor Capital Advisors Inc. - MarketBeat

FY2024 EPS Forecast for LeMaitre Vascular Boosted by Analyst - MarketBeat

LeMaitre Vascular: Market Catching On To Dividend Growth Story (NASDAQ:LMAT) - Seeking Alpha

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Plans Quarterly Dividend of $0.16 - MarketBeat

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by F M Investments LLC - MarketBeat

LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Simply Wall St

LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2024 Earnings Call Transcript - Insider Monkey

LeMaitre Vascular (NASDAQ:LMAT) Hits New 12-Month High Following Earnings Beat - Defense World

LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: R - GuruFocus.com

LeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat

LeMaitre to Participate at Upcoming Investor Conferences in November - GlobeNewswire

Earnings call: LeMaitre Vascular reports robust Q3 growth, plans expansion By Investing.com - Investing.com South Africa

LeMaitre Vascular (NASDAQ:LMAT) Earns Outperform Rating from Oppenheimer - MarketBeat

Earnings call: LeMaitre Vascular reports robust Q3 growth, plans expansion - Investing.com

LeMaitre Vascular Inc (LMAT) Trading 12.71% Higher on Nov 1 - GuruFocus.com

LeMaitre Vascular (NASDAQ:LMAT) Given New $93.00 Price Target at Barrington Research - MarketBeat

In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular - Benzinga

LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ... - Yahoo Finance

LeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year High on Earnings Beat - MarketBeat

LeMaitre Vascular stock target upgraded, keeps buy rating on strong Q3 results - Investing.com UK

Conestoga Capital Advisors LLC Purchases 36,850 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat

LeMaitre: Q3 Earnings Snapshot - The Advocate

LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance

LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings: EPS of $0.49 Beats Estimates, Revenue Hits $54.8 Million - GuruFocus.com

LeMaitre Q3 2024 Financial Results - GlobeNewswire

Congress Asset Management Co. Acquires 18,295 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat

LeMaitre Vascular Q3 2024 Earnings Preview - MSN

6,169 Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Purchased by Smith Group Asset Management LLC - MarketBeat

Hennion & Walsh Asset Management Inc. Has $1.66 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat

Centene Stock Rises 29% in a Year: Evaluating the Road Ahead - MSN

Ausbil Investment Management Ltd Has $1.23 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat

LeMaitre Vascular (LMAT) Set to Announce Earnings on Thursday - MarketBeat

(LMAT) Investment Analysis - Stock Traders Daily

LeMaitre Vascular, Inc. (NASDAQ:LMAT) is Copeland Capital Management LLC's 4th Largest Position - MarketBeat

Insiders At LeMaitre Vascular Sold US$23m In Stock, Alluding To Potential Weakness - Simply Wall St

Cantor Fitzgerald Initiates Coverage of LeMaitre Vascular (LMAT) with Neutral Recommendation - MSN

BAX or LMAT: Which Is the Better Value Stock Right Now? - Yahoo Finance

Vascular Graft Market to Hit $8.1 Billion by 2030 | Cordis, - openPR

YieldBoost LeMaitre Vascular To 13.2% Using Options - Nasdaq

Brokers Issue Forecasts for LeMaitre Vascular, Inc.'s FY2024 Earnings (NASDAQ:LMAT) - MarketBeat

GAMMA Investing LLC Raises Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World

LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024 - The Manila Times

Cantor Fitzgerald sets price target, neutral rating on LeMaitre Vascular shares - Investing.com Canada

Cardiovascular And Soft Tissue Repair Patches Market Market - openPR

Cantor Fitzgerald Begins Coverage on LeMaitre Vascular (NASDAQ:LMAT) - MarketBeat

Analyst Scoreboard: 4 Ratings For LeMaitre Vascular - Benzinga

The Manufacturers Life Insurance Company Grows Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World

LeMaitre Vascular And 4 Other Stocks Have Very High Payout Ratio - Via News Agency

Lemaitre Vascular Inc Azioni (LMAT) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a LMAT